Pathophysiology of altered glomerular function in aminoglycoside-treated rats

Area of Science:

• Nephrology
• Pharmacology
• Toxicology

Background:

• Aminoglycosides like gentamicin and tobramycin are crucial antibiotics.
• Nephrotoxicity is a known side effect of aminoglycosides.
• The specific impact on glomerular function requires further elucidation.

Purpose of the Study:

• To compare the effects of gentamicin and tobramycin on rat glomerular function.
• To investigate the role of angiotensin II (AII) generation in gentamicin-induced nephrotoxicity.

Main Methods:

• Three groups of rats received either gentamicin, tobramycin, or served as controls.
• Two additional groups were treated with gentamicin alongside interventions to suppress AII generation (saline or captopril).
• Single nephron glomerular filtration rate (SNGFR), glomerular capillary ultrafiltration coefficient (Kf), and glomerular plasma flow rate (QA) were measured.

Main Results:

• Gentamicin significantly reduced SNGFR, Kf, and QA compared to controls and tobramycin.
• Suppression of AII generation partially blunted gentamicin's effects (saline) and largely abolished them (captopril).
• Proximal tubule damage was observed with both antibiotics, but glomerular effects were more pronounced with gentamicin.

Conclusions:

• Gentamicin causes greater glomerular functional impairment than tobramycin at the studied dosage.
• The renin-angiotensin system, specifically AII generation, plays a role in gentamicin's nephrotoxic mechanism.
• Captopril's ability to mitigate these effects suggests a therapeutic target for aminoglycoside nephrotoxicity.